Surge

Provider of intraoperative immunotherapy services for cancer patients

placeCambridge, Massachusetts, United States calendar_todayFounded 2020 groups6 employees language surgetx.com

Registered entities

Investor mix

10 investors on record; lead investors include Bioluminescence Ventures, Camford Capital.

Investor typeCountShare
Venture capital550%
Bank & private debt220%
Other / undisclosed330%
Coming soon